Suppression of Metastasis by Primary Tumor and Acceleration of Metastasis Following Primary Tumor Resection: A Natural Law?
We study metastatic cancer progression through an extremely general individual-patient mathematical model that is rooted in the contemporary understanding of the underlying biomedical processes yet is essentially free of specific biological assumptions of mechanistic nature. The model accounts for primary tumor growth and resection, shedding of metastases off the primary tumor and their selection, dormancy and growth in a given secondary site. However, functional parameters descriptive of these processes are assumed to be essentially arbitrary. In spite of such generality, the model allows for computing the distribution of site-specific sizes of detectable metastases in closed form. Under the assumption of exponential growth of metastases before and after primary tumor resection, we showed that, regardless of other model parameters and for every set of site-specific volumes of detected metastases, the model-based likelihood-maximizing scenario is always the same: complete suppression of metastatic growth before primary tumor resection followed by an abrupt growth acceleration after surgery. This scenario is commonly observed in clinical practice and is supported by a wealth of experimental and clinical studies conducted over the last 110 years. Furthermore, several biological mechanisms have been identified that could bring about suppression of metastasis by the primary tumor and accelerated vascularization and growth of metastases after primary tumor resection. To the best of our knowledge, the methodology for uncovering general biomedical principles developed in this work is new.
KeywordsAngiogenesis Dormancy Metastasis Method of maximum likelihood Poisson process Primary tumor
Incisive and constructive comments by the two anonymous reviewers have helped the authors to considerably improve the manuscript. The reviewers’ suggestions are greatly appreciated.
- DeWys WD (1972) Studies correlating the growth rate of a tumor and its metastases and providing evidence for tumor-related systemic growth-retarding factors. Cancer Res 32:374–379Google Scholar
- Ehrlich P (1906) Experimentelle Karzinomstudien an Mäusen. Arch Koiglichen Inst Exp Ther Frankfurt am Main 1:65–103 (in German)Google Scholar
- Fidler IA (1990) Critical factors in the biology of human cancer metastasis: twenty-eighth G. H. A. Clowes memorial award lecture. Cancer Res 50:6130–6138Google Scholar
- Folkman J (1974) Tumor angiogenesis factor. Cancer Res 34:2109–2113Google Scholar
- Folkman J (2002) Role of angiogenesis in tumor growth and metastasis. Semin Oncol 29(6), Suppl 16:15–18Google Scholar
- Hanin LG (2008) Distribution of the sizes of metastases: mathematical and biomedical considerations. In: Tan WY, Hanin LG (eds) Handbook of cancer models with applications. World Scientific, Singapore, pp 141–169Google Scholar
- Hanin LG (2013) Seeing the invisible: how mathematical models uncover tumor dormancy, reconstruct the natural history of cancer and assess the effects of treatment. In: Almog N, Enderling H, Hlatky L (eds) Systems biology of tumor dormancy. Advances in experimental medicine and biology, vol 734. Springer, New York, pp 261–282CrossRefGoogle Scholar
- Hiller J, Schier R, Riedel B (2017) Perioperative biologic perturbation and cancer surgery: targeting the adrenergic-inflammatory response and microcirculatory dysregulation. In: Retsky M, Demicheli R (eds) Perioperative inflammation as a triggering origin of metastasis development. Springer, New York, pp 83–107CrossRefGoogle Scholar
- Prehn RT (1993) Two competing influences that may explain concomitant tumor resistance. Cancer Res 53:3266–3269Google Scholar
- Sugarbaker E, Thornswaite J, Ketcham A (1977) Inhibitory effect of a primary tumor on metastasis. In: Day S, Myers W, Stansly P, Garattini S, Lewis M (eds) Progress in cancer research and therapy, vol 5. Raven Press, New York, pp 227–240Google Scholar
- Tyzzer EE (1913) Factors in the production and growth of tumor metastases. J Med Res 28:309–332Google Scholar